Login / Signup

Priorities for efficacy trials of gender-affirming hormone therapy with estrogen: collaborative design and results of a community survey.

Shira GrockJane WeinrebKristen C WilliamsAmy WeimerSarah FadichReema PatelAtara GeftStanley Korenman
Published in: Hormones (Athens, Greece) (2024)
The goals and experiences of individuals seeking GAHT-E are diverse. Future clinical trials of GAHT-E should be grounded in the needs and priorities of community stakeholders.
Keyphrases
  • mental health
  • clinical trial
  • healthcare
  • cross sectional
  • quality improvement
  • estrogen receptor
  • randomized controlled trial
  • stem cells
  • open label
  • phase ii
  • global health
  • mesenchymal stem cells
  • phase iii